Recent Headlines
Within Pharmaceuticals
Trevigen Launches High-Throughput PARP/Apoptosis Assays
Trevigen launches High-Throughput PARP/Apoptosis Assays ideal for measuring the activity of PARP in 96-well plates. Cell extracts can be obtained using their newly-developed, higher-throughput procedure before, during and after apoptosis induction. During apoptosis, PARP-1 which catalyzes the NAD... - February 20, 2008 - Trevigen, Inc.
Clinical Trials in Russia, 4th Quarter 2007
On February 18, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects... - February 20, 2008 - Synergy Research Group
Menopause Relief, Natural and Easy
Mitamins has launched a specific supplement formula from Dr. Balch focused on supporting Menopause treatment. This natural menopause treatment formula can balance hormone levels and promote the general well-being of women, as well as regulating the menstrual cycle. The formula includes all the essential natural ingredients to target this condition, for example, vitamin D, vitamin E, Calcium, Dong Quai Extract, Licorice Extract and Chaste Tree Extract. - February 20, 2008 - Mitamins Inc.
Achieve Relief for Migraines Naturally
At Mitamins, a new natural supplement formula aiming to fight Migraine Headache has been launched by Dr. Balch. This natural migraine treatment formula can support optimal nervous system health and maintain circulation to the brain. Migraines and Calcium are included in the formula which play an... - February 17, 2008 - Mitamins Inc.
AnaSpec Introduces New Suite of Fluorescently Labeled GST & 6xHis Tag Antibodies
AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength... - February 16, 2008 - AnaSpec, EGT Group
Mini Thin Rush Liquid Energy Shot Signs on as Exclusive Energy Drink Sponsor of Winter Music Conference 2008
Revolutionary new energy drink partners with Dance Music Industry’s most prominent annual forum to celebrate dance music as a cultural art form. - February 14, 2008 - BDI Marketing
BDI Marketing Names Steven Style Group as Exclusive Marketing Communications Agency for Mini Thin Rush
Revolutionary New Energy Supplement Brand, Providing 6 Hours of Energy without the Crash Associated with Traditional Energy Drinks, Joins Roster of Clientele at Renowned New York City Marketing Communications Firm. - February 13, 2008 - BDI Marketing
AnaSpec Introduces 46 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100... - February 13, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 21 New Anti-Tau Antibodies
AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a... - February 11, 2008 - AnaSpec, EGT Group
Vascular BioSciences Awarded Phase 1 STTR Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Pulmonary Hypertension Research
Vascular BioSciences announced today it has received a STTR Phase 1 grant from the National Heart Lung Blood Institute of the National Institutes of Health in the amount of $165,745. The STTR award, “Targeting Pulmonary Hypertension with R-Ras,” will be performed in collaboration with... - February 10, 2008 - Vascular BioSciences, Inc
ISOfemme High Protein Smoothie Exclusively for Women
ISOfemme, a revolutionary protein smoothie created just for women, is changing the way females nourish their figure. It’s a great-tasting high protein smoothie that’s extraordinarily low in carbs and sugar and contains zero estrogenic proteins. - February 08, 2008 - Allmax Nutrition
NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration for Monoclonal Antibody Recovery, Concentration and Diafiltration
NCSRT is presenting “A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow™ TFF” at the Waterside Conference in Miami, FL. The data, generated by Viventia Biotech of Winnipeg, Manitoba, Canada, demonstrates... - February 08, 2008 - NCSRT, Inc.
Fuco Xanthin / Fucoselean for Weight Loss
Natures Benefit has launched a physician formulated weight loss product containing fucoxanthin. Fucoselean™ is a proprietary MD Formulated marine nutraceutical that may promote thermogenesis. It contains natural Fucoxanthin from brown marine vegetables concentrated at the clinically... - February 04, 2008 - Natures Benefit
Leading North America Distributor Announces Partnership with Internationally Recognized Health Organization
Statens Serum Institut (SSI), Copenhagen, Denmark and Atlantic Biologicals Corp., Miami, FL US, have formed a partnership to introduce a new diagnostic product to North America. Flexicult, designed for testing for urinary tract infection (“UTI”), has been in use in Denmark and is now... - February 04, 2008 - Atlantic Biologicals
The First Web 2.0 Pharmaceutical News Portal
World Pharma News project is launching a Web 2.0 pharmaceutical news platform, named as well World Pharma News but with attached '.net' extension. - February 04, 2008 - World Pharma News
Mitamins Launched Specific Supplement Formula Focused on Natural Thyroid Gland Support
At Mitamins, Dr. Balch has launched a specific supplement formula focused on Thyroid Gland Support. This natural supplement formula for the thyroid contains important components necessary for optimal function of the thyroid gland, for example, Bladderwrack Extract, Iodine in which is essential for... - February 03, 2008 - Mitamins Inc.
A Natural Short Cut to Reduce Extra Fat
At Mitamins, Dr. Balch has launched a specific supplement formula focused on weight loss. This natural treatment formula is designed as a weight loss supplement that will work alongside a healthy diet and regular exercise. Effective components, (for example, L-Carnitine), have been added to promote fat-burning processes. Protection and supplemental nutrition such as L-Glutamine is provided with botanicals. - February 01, 2008 - Mitamins Inc.
Baxa Corporation Launches New Web Site
Baxa announces the launch of its new corporate Web site with enhanced user features and technical content. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. - January 31, 2008 - Baxa Corporation
Colorado BioScience Association and Six Economic Development Groups Tout Colorado’s Strengths to the Medical Device Industry at MD&M West in Anaheim
Representatives from the Colorado BioScience Association (CBSA) and six of the state’s economic development entities are marketing Colorado as a desirable medical device manufacturing hub at the 24th annual Medical Device & Manufacturing (MD&M) West Expo. - January 31, 2008 - Colorado BioScience Association
Alleviate the Symptoms of Depression Successfully
Mitamins has launched a specific supplement formula from Dr. Balch focused on alleviating the symptoms of depression. This natural treatment formula includes essential natural ingredients that can promote a positive and enduring healthy mental state, such as Choline Bitartrate, Inositol, PABA, DHEA, Omega - 3 Fatty Acids, St. John's Wort Extract, and Pantothenic Acid. - January 31, 2008 - Mitamins Inc.
Natural Supplement for Diabetes Sufferers
At Mitamins, a specific supplement formula from Dr. Balch designed to target Diabetes has been launched. This natural treatment formula includes ingredients that can optimize blood sugar control and may improve the overall health condition. Chromium in it helps to regulate blood sugar level and indirectly affects level of fats in the blood, and taurine may improve insulin sensitivity and decrease cholesterol level. - January 30, 2008 - Mitamins Inc.
Ron Newcomb Named President & CEO of Resveratrol, Inc.
Ron Newcomb has been named president and CEO of Resveratrol, Inc., a nutraceutical company. Newcomb plans to increase sales of Resveratrol’s three products, NutraGrape™, a dietary nutritional supplement made of Muscadine grape seeds; The Vine® facial cream and The Vine® body lotion. Muscadine grape seeds have very high levels of antioxidants, which help fight free radical damage to your body. - January 29, 2008 - NutraGrape
Conquer High Cholesterol Thoroughly
Mitamins has launched a new supplement formula from Dr. Balch especially designed to target High Cholesterol. This natural treatment formula is a comprehensive approach to lower cholesterol, aiming for optimum cardiovascular health. Red Yeast Rice in the formula can inhibit cholesterol production in the liver and may lower cholesterol levels. - January 29, 2008 - Mitamins Inc.
Dr Balch High Blood Pressure Formula
Mitamins launches Dr Balch’s High Blood Pressure condition specific supplement formula: Vitamin C 100mg, Calcium 100mg, Magnesium 50mg, CoQ-10 60mg, Flax Seed Powder 50mg, Bioflavonoid Concentrate 100mg, Garlic Extract 100mg, Hawthorn Extract 250mg, Reishi Extract 50mg, Taurine... - January 27, 2008 - Mitamins Inc.
AnaSpec Introduces 9 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group
Growing Mobile Cath Lab Market Leads to Expansion at Modular Devices Inc.
Move to larger production facility will allow company to keep up with the growing demand for Mobile and Modular Cardiac/Vascular & EP Lab rentals. - January 26, 2008 - Modular Devices Inc.
Xcelience Expands Its Early Drug Development Capabilities
The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC
Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock® Set Saver
New Baxa eCampaign targets IV Nurses to introduce the PadLock Set Saver and honors nurses for their dedication to patients. The PadLock Set Saver device is designed to promote best practice for aseptic IV administration set storage, preventing contamination of the administration set when disconnected from the patient. The Set Saver also eliminates the use of IV administration set caps, which are a known choking hazard – especially in pediatric applications. - January 25, 2008 - Baxa Corporation
Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.
The First Fully Cementless Knee Replacement Performed at CentraState by Orthopedic Surgeons from the Advanced Orthopedics and Sports Medicine Institute in Freehold, NJ
On Tuesday, November 20th, Dr Michael Greller and Dr Alan Nasar, orthopedic surgeons from the Advanced Orthopedics and Sports Medicine Institute in Freehold, New Jersey, performed the first fully cementless, minimally invasive total knee replacement using trabecular metal technology in the history of CentraState Medical Center, Freehold, NJ. - January 24, 2008 - Advanced Orthopedics and Sports Medicine Institute, PC
Minimizing and Treating Sebaceous Cysts
Mitamins has launched a new supplement formula from Dr. Balch especially designed to target Sebaceous Cysts. This natural treatment formula is targeted at building the body's natural clearance and preventative processes, which work against sebaceous cysts. The formula includes all the essential natural ingredients to target this condition. - January 24, 2008 - Mitamins Inc.
AnaSpec Announces a Broad Selection of T-Cell Epitopes
AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group
Control Lupus Symptoms, Lead a Full Life
At Mitamins, a new supplement formula targeted at Lupus from Dr. Balch has been launched. This natural lupus treatment formula is designed to control the symptoms of lupus as well as promote overall health. Botanicals, such as ginger, having strong anti-inflammatory properties are included. The... - January 23, 2008 - Mitamins Inc.
Relief from Tinnitus
Dr. Balch has launched a Mitamins supplement designed to target Tinnitus. This supplement contains Vitamins B-12 and B-6, as well as the nutrients Thiamin, Riboflavin, Niacin, Folate, Biotin, Magnesium, Zinc, Copper, and Pantothenic Acid. It also includes Choline Bitartrate, Inositol, PABA, and Gingko Extract. - January 21, 2008 - Mitamins Inc.
Improve Quality of Life with Supplement Targeting Hypothyroidism
Mitamins launches a formula by Dr. Balch that is specified to target Hypothyroidism. It contains Vitamins A, C, D, E, K, B-6, and B-12, as well as the nutrients Calcium, Iodine, Magnesium, Thiamin, Riboflavin, Niacin, Folate, Biotin, Copper, Selenium, Maganese, Chromium, Potassium, Pantothenic... - January 21, 2008 - Mitamins Inc.
Defeat Narcolepsy the Natural Way
Mitamins launches a new formula from Dr. Balch that is specified to target Narcolepsy. This supplement contains a complete spectrum of B vitamins, which are especially nourishing to the brain: Thiamin, Riboflavin, Niacin, Vitamin B12, Folate, Pantothenic Acid and Vitamin B6. The formula also includes an Amino Acid Mix, as well as L-Tyrosine, L-Glutamine, Lecithin and Ginkgo Extract. Necessary minerals such as Calcium, Magnesium and Chromium are included as well. - January 21, 2008 - Mitamins Inc.
Supplement for Emphysema: Enhance and Support Lung Health
From Sunnyvale, California - At Mitamins, a new supplement formula from Dr. Balch, which is targeted at Emphysema has been launched. This natural emphysema formula is focused on lung system recovery and repair. Botanicals such as Ginkgo Biloba, used to help with peripheral circulation, are included alongside powerful immunity-enhancing components such as Astragalus. Smoking- and stress-related nutritional deficiencies are addressed with a variety of essentials. - January 21, 2008 - Mitamins Inc.
Calcium Supplementation and Heart Attack Risk? Vitamin K2 May be a Solution.
Industry expert Scott Rosenbush strongly recommends vitamin K2 supplementation to help ensure bone and heart health. As the most bioactive and longest lasting form of vitamin K, menaquinone-7 is ideal for dietary supplements and functional foods. - January 19, 2008 - P.L. Thomas & Co., Inc.
Anavex Strengthens Board of Directors
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.
Anavex 7-1037 Demonstrates Chemotherapeutic Potential Without Toxic Side Effects for the Treatment of Colorectal Cancer, Other Types of Solid Tumors
ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.
Anavex Advances Drug Candidate for Treatment of Alzheimer's Disease
Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits. - January 16, 2008 - Anavex Life Sciences Corp.
Trevigen Launches Cultrex BME PathClear
Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc.
Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug
Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan... - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
Axium Awarded Phase III Clinical Trial Management Contract for OxThera’s Oxabact™
Axium Healthcare Pharmacy announced today that it has been awarded the clinical trial management contract for OxThera’s Oxabact™. Oxabact™ is manufactured by OxThera. - January 09, 2008 - Axium Healthcare Pharmacy, Inc.
Successful CentraState HealthWatch Cable TV Pilot Show Featuring Freehold NJ Orthopedic Surgeon Dr Alan Nasar Rewarded with Extended Life and Wider Distribution
The CentraState HealthWatch cable TV show featuring Freehold, NJ orthopedic surgeon Dr Alan Nasar, has been extended through January across an increased number of New Jersey television stations. Alan S. Nasar MD, a fellowship-trained joint replacement orthopedic surgeon at the Advanced Orthopedics and Sports Medicine Institute in Freehold, features in one segment of the half-hour show discussing advances in joint replacement surgery and pain management with host Gary Gellman. - January 07, 2008 - Advanced Orthopedics and Sports Medicine Institute, PC
DDC's Laboratory Director Now Chair of AABB Parentage Testing Program
Effective January 1, 2008, DDC's Laboratory Director, Dr. Michael Baird, is chairman of the Chair of the Relationship Testing Standards Program Unit of the AABB (formerly American Association of Blood Banks). In this capacity, Dr. Baird is leading the committee to develop the 9th edition of the... - January 05, 2008 - DNA Diagnostics Center
AnaSpec Introduces Ten New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group